The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 08, 2015

Filed:

Oct. 05, 2010
Applicants:

Joseph J. Buggy, Mountain View, CA (US);

Sriram Balasubramanian, San Carlos, CA (US);

Inventors:

Joseph J. Buggy, Mountain View, CA (US);

Sriram Balasubramanian, San Carlos, CA (US);

Assignee:

PHARMACYCLICS, INC., Sunnyvale, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 21/04 (2006.01); C12N 15/11 (2006.01); G01N 33/574 (2006.01); C12N 5/09 (2010.01); C12Q 1/68 (2006.01);
U.S. Cl.
CPC ...
G01N 33/57492 (2013.01); C12N 5/0693 (2013.01); C12Q 1/6886 (2013.01); G01N 33/57419 (2013.01); C07H 21/04 (2013.01); C12N 15/11 (2013.01); C12N 2503/02 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/136 (2013.01); G01N 2800/52 (2013.01);
Abstract

Described herein are methods and compositions for determining whether a particular cancer is resistant to or susceptible to a histone deacetylase inhibitor or to histone deacetylase inhibitors. The methods include analysis of the expression levels of at least four biomarker genes associated with response to a histone deacetylase inhibitor. Also described herein are methods and compositions for increasing the likelihood of a therapeutically effective treatment in a patient, comprising an analysis of the expression levels of at least four biomarker genes associated with response to a histone deacetylase inhibitor. Also described herein are isolated populations of nucleic acids derived from a cancer sensitive to or resistant to a histone deacetylase inhibitor. Further described are kits and indications that are optionally used in conjunction with the aforementioned methods and compositions.


Find Patent Forward Citations

Loading…